Friday 6 November 2026 Export TFX’s income statement to Excel — free account

Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue: +28.9%
EPS: −17.3%
Free cash flow: +220.1%
Total debt: +47.7%

Quarter to June 2026, against a year earlier

Dividend growth 25 yrs

152.16 2.29 +1.53%

Follow TFX

Alert me

Market cap: $6.5B
P/E: 0.0×
Fwd P/E: 37.4×
Dividend yield: 0.89%
F-score: 5/9
Altman Z: 2.04
Beneish M: −2.21
Dividend safety: 20/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Teleflex Incorporated (TFX) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Americas	1,279	64.19%
EMEA	472	23.71%
Asia	241	12.10%
Gross margin		56.24%
Operating margin		5.94%
Pre-tax margin		1.23%

Revenue by product or service $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Vascular	918 46.05%	904 53.16%	841 49.12%	684 24.49%	700 24.92%	658 25.92%	601 23.15%	575 23.50%	540 25.17%
Interventional	648 32.51%	397 23.38%	407 23.78%	445 15.94%	428 15.22%	382 15.07%	428 16.47%	395 16.15%	325 15.13%
Surgical	418 20.98%	405 23.82%	388 22.68%	393 14.08%	378 13.45%	317 12.50%	370 14.26%	359 14.65%	356 16.59%
Other	9 0.45%	(6) (0.36%)	76 4.42%	285 10.22%	337 11.98%	367 14.48%	347 13.38%	367 14.98%	359 16.71%
Anesthesia	—	—	—	389 13.93%	380 13.53%	302 11.91%	338 13.04%	349 14.27%	345 16.06%
Interventional urology	—	—	—	323 11.57%	342 12.16%	290 11.43%	290 11.19%	197 8.04%	39 1.82%
OEM	—	—	—	273 9.77%	246 8.74%	220 8.68%	221 8.50%	206 8.41%	183 8.52%
Revenue	1,993	1,700	1,712	2,791	2,810	2,537	2,595	2,448	2,146

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2009
Americas	1,279 64.19%	1,157 68.07%	1,181 68.95%	1,926 69.02%	1,659 59.06%	1,465 57.74%	1,492 57.50%	1,352 55.21%	1,141 53.18%	295 15.80%	284 15.70%	311 16.91%	272 16.05%	223 14.36%	—
EMEA	472 23.71%	340 20.02%	317 18.51%	558 20.01%	607 21.60%	585 23.05%	588 22.66%	604 24.66%	553 25.75%	511 27.35%	514 28.43%	593 32.23%	557 32.86%	510 32.90%	—
Asia	241 12.10%	202 11.91%	215 12.54%	306 10.98%	298 10.60%	267 10.52%	294 11.34%	287 11.72%	269 12.54%	249 13.35%	242 13.36%	238 12.92%	207 12.22%	174 11.20%	—
OEM	—	—	—	—	246 8.74%	220 8.68%	221 8.50%	206 8.41%	183 8.52%	161 8.62%	149 8.26%	144 7.82%	131 7.73%	140 9.04%	—
Anesthesia North America	—	—	—	—	—	—	—	—	—	199 10.64%	189 10.46%	184 10.00%	156 9.19%	180 11.63%	—
All other segments [member]	—	—	—	—	—	—	—	—	—	198 10.60%	194 10.74%	220 11.95%	226 13.34%	180 11.59%	—
Surgical North America	—	—	—	—	—	—	—	—	—	172 9.22%	161 8.91%	150 8.16%	146 8.61%	144 9.28%	—
Interventional North America	—	—	—	—	—	—	—	—	—	82 4.41%	75 4.16%	—	—	—	—
Critical Care	—	—	—	—	—	—	—	—	—	—	—	—	—	—	939 65.46%
Surgical Care	—	—	—	—	—	—	—	—	—	—	—	—	—	—	261 18.16%
Oem And Development Services	—	—	—	—	—	—	—	—	—	—	—	—	—	—	150 10.44%
Cardiac Care	—	—	—	—	—	—	—	—	—	—	—	—	—	—	71 4.93%
Other [Member] (Deprecated 2012-01-31)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	14 1.00%
Revenue	1,993	1,700	1,712	2,791	2,810	2,537	2,595	2,448	2,146	1,868	1,810	1,840	1,696	1,551	1,435

Gross profit by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2009
Americas	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
EMEA	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Asia	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Gross profit	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

Revenue by region $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2009
UNITED STATES	1,182 59.31%	1,079 63.51%	1,107 64.64%	1,786 64.01%	1,769 62.98%	1,567 61.77%	1,606 61.89%	1,449 59.20%	1,255 58.46%	791 55.14%
Europe	485 24.33%	348 20.47%	330 19.27%	622 22.30%	665 23.67%	647 25.48%	652 25.12%	671 27.42%	591 27.55%	—
Asia Pacific	218 10.94%	180 10.57%	188 10.98%	271 9.70%	263 9.36%	230 9.08%	241 9.30%	234 9.56%	220 10.26%	—
All other	108 5.43%	93 5.46%	88 5.11%	111 3.99%	112 3.99%	93 3.67%	96 3.69%	94 3.82%	80 3.73%	94 6.58%
Other Europe	—	—	—	—	—	—	—	—	—	362 25.21%
Delaware	—	—	—	—	—	—	—	—	—	141 9.85%
Other Americas	—	—	—	—	—	—	—	—	—	46 3.23%
Revenue	1,993	1,700	1,712	2,791	2,810	2,537	2,595	2,448	2,146	1,435

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.